Article
Loss of TP53 cooperates with c-MET overexpression to drive hepatocarcinogenesis
2022-11-03
Abstract excerpt
<title>Abstract</title> <p>Hepatocellular carcinoma (HCC) is a deadly malignancy with high genetic heterogeneity. <italic>TP53</italic> loss of function (LOF) mutation and c-MET activation are frequent events in human HCCs. Here, we discovered that the simultaneous LOF mutations in <italic>TP53</italic> and activation of c-MET occur in ~ 20% of human HCCs, and these patients show a poor prognosis. Importantly, we...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e0fae5dc-790d-5c7f-8ca7-37e8a1978027
- DOI
- 10.21203/rs.3.rs-2176178/v1
